We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.40 | -0.24% | 169.00 | 168.60 | 169.00 | 170.40 | 163.00 | 163.00 | 23,434 | 10:41:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 65.12M | -65.7M | -0.2744 | -6.18 | 405.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/3/2024 10:46 | More than a bit! Especially when royalty payments added on too | edwardt | |
16/3/2024 10:32 | Karuna sale scheduled to complete before US markets open on Monday at which point our marketcap should broadly equal net cash, which is a bit silly. | rimau1 | |
15/3/2024 18:15 | We are expecting the merger to close on Monday I believe so next week could be the week? | lendmeafiver | |
14/3/2024 19:06 | You got there in the end Colin! They have stated this from the start... | rimau1 | |
14/3/2024 18:41 | . The Company intends to update its capital return strategy in light of the expected closing of the pending merger between its Founded Entity, Karuna Therapeutics, Inc. (Nasdaq: KRTX), and Bristol Meyers Squibb (NYSE: BMY). | colinblackbourn | |
14/3/2024 13:48 | If it’s now legally binding, or will be on Monday, then PRTC should announce what they plan to do in terms of distribution rather than letting the market speculate. | lendmeafiver | |
14/3/2024 13:39 | i assume the deal has now gone binding from a legal perspective? | edwardt | |
14/3/2024 12:19 | Karuna is up 2.4pc pre market 330 | colinblackbourn | |
14/3/2024 12:09 | When the transaction completes (expected in Q2 vs Expected close 18th March What is the legal difference between the status on both dates i.e. close vs completion | takeiteasy | |
14/3/2024 11:52 | Thanks Colin, good spot. So when do we rerate is the question | rimau1 | |
14/3/2024 11:45 | Expected close 18th March | colinblackbourn | |
14/3/2024 11:44 | https://investors.ka | colinblackbourn | |
14/3/2024 08:49 | This is looking a bit (very) cheap.. why it's around this level still is a bit beyond me. Sector sentiment is all I can see. | swinsco | |
13/3/2024 15:52 | Post #1812 and #1776. When the transaction completes (expected in Q2) and they receive the cash they will communicate an updated capital returns policy. Returning cash is contingent on transaction completion. | rimau1 | |
13/3/2024 15:37 | Roughly when do we expect PRTC to announce what they are going to do with the Karuna proceeds? | lendmeafiver | |
13/3/2024 15:26 | Wait for 1.89! | rimau1 | |
13/3/2024 14:37 | tempted to buy more but i have no cash! | edwardt | |
13/3/2024 12:20 | Excellent news for LYT200, great example of the hidden value of the founding entities portfolio | rimau1 | |
13/3/2024 11:05 | FDA grants Orphan Drug designation for LYT200 in AML - confers tax credits and 7 years market exclusivity if drug approved for purpose. | mighunter | |
12/3/2024 22:16 | https://investors.ka | colinblackbourn | |
12/3/2024 21:38 | I’m in for more tmmw just needing a lovely handle for that cup 🍵 golden cross also | brianblu | |
12/3/2024 16:21 | Feel like some sort of news coming soon | brianblu | |
12/3/2024 11:10 | hopefully stock overhang gone... | edwardt | |
08/3/2024 16:14 | Let me know when you do Rimau1 enjoy the weekend p—steckers 🦉😉 | linton5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions